ArticleLeukemia2020
Soluble SLAMF7 is a predictive biomarker for elotuzumab therapy.
Atsushi Suzuki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleLeukemia2020
Atsushi Suzuki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.